CLINDAMYCIN PHOSPHA

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 20 units of Clindamycin Phosphate (NSN 6505012850797) at a total price of $373.00, with a unit price of $18.65. The award was made on July 14, 2026, under a Lowest Price Technically Acceptable (LPTA) acquisition strategy, with no non-price evaluation factors considered. The item is to be delivered by July 29, 2026, to Fort Stewart, Georgia, under FOB Destination terms, meaning the contractor is responsible for freight costs and risk transfers upon arrival. The delivery must be shipped by the fastest traceable means, excluding parcel post, and all packaging and documentation must include required traceability identifiers such as the Tracking Control Number W33RBS60330166, though specific military packaging standards like MIL-STD-129 or MIL-STD-2073 are not explicitly mandated. The contracting officer, Lisa Quinn, and administrative support officer, Shairy M. Cartagena, are identified, with payments to be processed through the Defense Finance and Accounting Service in Columbus, Ohio. The awardee is certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, triggering applicable federal reporting obligations under FAR 19.301 and the WOSB Program. Inspection and acceptance are the responsibility of the Government at the delivery point, based on conformance to contract requirements without reference to specific external quality standards. The contract contains no options, variations, or escalation clauses, and no formal contract clauses, attachments, or special requirements were documented in the available records. Invoicing appears to rely on manual voucher systems rather than electronic platforms such as WAWF or IPP.